Coldstream Capital Management Inc. Has $566,000 Stock Position in Tenet Healthcare Co. (NYSE:THC)

Coldstream Capital Management Inc. raised its holdings in shares of Tenet Healthcare Co. (NYSE:THCFree Report) by 2.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,406 shares of the company’s stock after acquiring an additional 74 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Tenet Healthcare were worth $566,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Plato Investment Management Ltd purchased a new position in Tenet Healthcare during the third quarter valued at approximately $28,000. ORG Wealth Partners LLC purchased a new position in shares of Tenet Healthcare during the 3rd quarter valued at $30,000. Financial Management Professionals Inc. raised its holdings in shares of Tenet Healthcare by 2,222.2% during the third quarter. Financial Management Professionals Inc. now owns 209 shares of the company’s stock worth $35,000 after acquiring an additional 200 shares in the last quarter. Innealta Capital LLC purchased a new position in Tenet Healthcare in the second quarter valued at about $28,000. Finally, True Wealth Design LLC acquired a new position in Tenet Healthcare in the 3rd quarter worth about $38,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Buying and Selling at Tenet Healthcare

In other news, EVP Lisa Y. Foo sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $155.94, for a total value of $623,760.00. Following the sale, the executive vice president now directly owns 15,566 shares in the company, valued at approximately $2,427,362.04. This represents a 20.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.93% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on THC. KeyCorp assumed coverage on Tenet Healthcare in a report on Friday, October 11th. They issued an “overweight” rating and a $200.00 price objective on the stock. Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price target on the stock. in a report on Friday, November 22nd. Wells Fargo & Company cut shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $205.00 to $150.00 in a report on Monday, November 25th. Cantor Fitzgerald boosted their price target on Tenet Healthcare from $168.00 to $177.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Finally, The Goldman Sachs Group increased their price objective on Tenet Healthcare from $173.00 to $196.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Two investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare has a consensus rating of “Buy” and an average price target of $168.19.

Get Our Latest Report on THC

Tenet Healthcare Stock Performance

NYSE:THC opened at $136.71 on Friday. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58. The firm’s 50-day moving average is $152.09 and its 200-day moving average is $149.13. Tenet Healthcare Co. has a 52-week low of $73.21 and a 52-week high of $171.20. The company has a market cap of $13.00 billion, a price-to-earnings ratio of 4.38, a PEG ratio of 0.63 and a beta of 2.06.

Tenet Healthcare (NYSE:THCGet Free Report) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $2.33 by $0.60. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.05 billion. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. The company’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter last year, the company earned $1.44 EPS. Equities research analysts anticipate that Tenet Healthcare Co. will post 11.38 earnings per share for the current year.

Tenet Healthcare Company Profile

(Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Read More

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THCFree Report).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.